AAIC26: Roche charts expanded course for Alzheimer’s therapy, touts long-term anti-amyloid impact
Roche is eyeing a wider patient population for its anti-amyloid Alzheimer’s hopeful, trontinemab, as the space increasingly examines…
Roche to Present New Elecsys Alzheimer’s Blood Test Data at AAIC 2026
Roche announced it will present 18 oral and poster presentations from its Alzheimer’s disease portfolio at the Alzheimer’s…
Roche to present 18 Alzheimer’s data at AAIC
Roche (OTCQX:RHHBY) will present extensive new Alzheimer’s disease data at AAIC 2026 in London on 12–15 July. The…
Genentech, Roche line up 18 AAIC Alzheimer’s data
See more from StockTitan in Google Search and AI answers.
Adds StockTitan as…